Merck & Co (US.MRK)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.MRK · YoY: 2026 Q1 vs 2025 Q1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 74.7% | ↑ |
| ROE | -9.2% | ↓ |
| Cash Conversion | - | → |
| D/E Ratio | 1.07 | ↓ |
| Gross Margin | 74.2% | → |
US.MRK (Merck & Co) | YoY: 2026 Q1 vs 2025 Q1 Metric Value YoY --------------------------- FCF Conversion 74.7% ↑ ROE -9.2% ↓ Cash Conversion - → D/E Ratio 1.07 ↓ Gross Margin 74.2% →
Key Metrics
US.MRK (Merck & Co) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY---------------------------FCF Conversion 74.7% ↑ROE -9.2% ↓Cash Conversion - →D/E Ratio 1.07 ↓Gross Margin 74.2% →Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies